Long-term outcome after admission for acute severe ulcerative colitis in Oxford: The 1992-1993 cohort

Inflammatory Bowel Diseases

Volumn 15, Issue 6, 2009, Pages 823-828

  Bojic, D ^a,b   Radojicic, Z ^c   Nedeljkovic Protic, M ^a   Al Ali, M ^a   Jewell, D P ^a   Travis, Simon P L ^a  

^a JOHN RADCLIFFE HOSPITAL   (United Kingdom)

^b Clinical Centre Zvezdara   (Serbia)

^c UNIVERSITY OF BELGRADE   (Serbia)

Author keywords

Colectomy; Cyclosporin; Severe ulcerative colitis; Steroids

Indexed keywords

AMINOSALICYLIC ACID; AZATHIOPRINE; CYCLOSPORIN;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL ASSESSMENT; COLON RESECTION; CROHN DISEASE; DISEASE DURATION; DRUG HYPERSENSITIVITY; EMERGENCY SURGERY; HISTOLOGY; HOSPITALIZATION; HUMAN; MAINTENANCE THERAPY; PRIORITY JOURNAL; RELAPSE; REMISSION; STEROID THERAPY; TREATMENT DURATION; TREATMENT RESPONSE; ULCERATIVE COLITIS;

ADULT; AZATHIOPRINE; COHORT STUDIES; COLECTOMY; COLITIS, ULCERATIVE; COST OF ILLNESS; CYCLOSPORINE; ENGLAND; FOLLOW-UP STUDIES; HOSPITALIZATION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KAPLAN-MEIERS ESTIMATE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; REMISSION INDUCTION; RETROSPECTIVE STUDIES; RISK FACTORS; SEVERITY OF ILLNESS INDEX; STEROIDS; TIME FACTORS;

EID: 67650237431     PISSN: 10780998     EISSN: 15364844     Source Type: Journal    
DOI: 10.1002/ibd.20843     Document Type: Article

References (18)

1. Edwards FC, Truelove SC. The course and prognosis of ulcerative colitis. Gut. 1963; 4:300-308.
2. Truelove SC, Witts LJ. Cortisone in ulcerative colitis: final report on a therapeutic trial. Br Med J. 1955;ii:1041-1048.
3. Jakobovits S, Travis SPL. The management of acute severe ulcerative colitis. Br Med Bull. 2006;75-76:131-144.
4. Turner D, Walsh C, Steinhart AH, et al. Response to corticosteroids in severe ulcerative colitis: a systematic review of the literature and meta-regression. Clin Gastro Hepatol. 2007;5:103-110.
5. Gupta S, Kesharvazian A, Hodgson HJF. Cyclosporin in ulcerative colitis. Lancet. 1984;2:1277-1278.
6. Campbell S, Travis SPL, Jewell DP. Ciclosporin use in acute ulcerative colitis: a long-term experience. Eur J Gastroenterol Hepatol. 2005;17: 79-84.
7. Moskovitz DN, Van Assche G, Maenhout B, et al. Incidence of colectomy during long-term follow up after cyclosporine-induced remission of severe ulcerative colitis. Clin Gastro Hepatol. 2006;4:760-765.
8. Fellerman K, Tanko Z, Herrlinger KR, et al. Response of refractory colitis to intravenous or oral tacrolimus (FK506). Inflamm Bowel Dis. 2002;8:478-479.
9. Järnerot G, Hertevig E, Ingalill FL, et al. Infliximab as rescue therapy in severe to moderately severe ulcerative colitis: a randomized, placebo-controlled study. Gastroenterology. 2005;128:1805-1811.
10. Travis SPL, Farrant JM, Ricketts C, et al. Predicting outcome in severe ulcerative colitis. Gut. 1996;38:905-910.
11. Satsangi J, Silverberg MS, Vermeire S, et al. The Montréal classification of inflammatory bowel disease: controversies, consensus and implications. Gut. 2006;55:745-753.
12. Leijonmarck CE, Persson PG, Hellers G. Factors affecting colectomy rate in ulcerative colitis: an epidemiologic study. Gut. 1990;31:329-333.
13. Hendriksen C, Kreiner S, Binder V. Long term prognosis in ulcerative colitis based on results from a regional patient group from the county of Copenhagen. Gut. 1985;26:158-163.
14. Farmer RG, Easley KA, Rankin GB. Clinical patterns, natural history and progression of ulcerative colitis. A long term follow-up of 1116 patients. Dig Dis Sci. 1993;38:1137-1146.
15. Vind I, Riis L, Jess T, et al. Increasing incidences of inflammatory bowel disease and decreasing surgery rates in Copenhagen City and County, 2003-2005: a population-based study from the Danish Crohn colitis database. Am J Gastroenterol. 2006;101:1274-1282.
16. Kohn A, Daperno M, Armuzzi A, et al. Infliximab in severe ulcerative colitis: short-term results of different infusion regimens and long-term follow-up. Aliment Pharmacol Ther. 2007;26:747-756.
17. Jakobovits SL, Jewell DP, Travis SPL. Infliximab for the treatment of ulcerative colitis: outcomes in Oxford from 2000 to 2006. Aliment Pharmacol Ther. 2007;25:1055-1060.
18. Langholz E, Munkholm P, Davidsen M, et al. Course of ulcerative colitis: analysis of changes in disease activity over years. Gastroenterology. 1994;107:3-11.